As of May 18
| +0.13 / +0.43%|
The 24 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 32.75, with a high estimate of 37.00 and a low estimate of 26.00. The median estimate represents a +7.55% increase from the last price of 30.45.
The current consensus among 26 polled investment analysts is to Buy stock in Boston Scientific Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.